Ticker: SAGE
2024-02-13 10:40:34
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapiesNEGATIVE4523.T-JP, SAGE, BIIB, ESALY, |
|
|
|
Found 4 articles